US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist
  • 30.740
  • -1.200-3.76%
Close May 17 16:00 ET
  • 30.090
  • -0.650-2.11%
Post 19:50 ET
1.80BMarket Cap12.10P/E (TTM)

Protagonist Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
254.95M
125.73%60M
60M
0
0
0
-2.84%26.58M
0
0
-62.08%859K
Operating revenue
--254.95M
125.73%60M
--60M
--0
--0
--0
-2.84%26.58M
--0
--0
-62.08%859K
Cost of revenue
Gross profit
Operating expense
35.04%48.64M
-2.72%153.65M
1.19%36.95M
18.65%38.33M
0.12%42.35M
-23.09%36.02M
3.10%157.95M
-19.98%36.52M
-26.94%32.3M
27.62%42.3M
Selling and administrative expenses
73.27%14.91M
5.52%33.49M
21.41%8.05M
11.03%7.66M
19.26%9.17M
-18.16%8.61M
16.70%31.74M
-8.65%6.63M
-4.89%6.9M
14.53%7.69M
-General and administrative expense
73.27%14.91M
5.52%33.49M
21.41%8.05M
11.03%7.66M
19.26%9.17M
-18.16%8.61M
16.70%31.74M
-8.65%6.63M
-4.89%6.9M
14.53%7.69M
Research and development costs
23.04%33.73M
-4.80%120.16M
-3.30%28.9M
20.71%30.66M
-4.13%33.18M
-24.51%27.42M
0.17%126.22M
-22.12%29.88M
-31.26%25.4M
30.94%34.61M
Operating profit
672.75%206.31M
28.71%-93.65M
163.12%23.05M
-18.65%-38.33M
-2.20%-42.35M
-70.63%-36.02M
-4.39%-131.37M
1.35%-36.52M
4.78%-32.3M
-34.20%-41.44M
Net non-operating interest income expense
75.67%4.38M
266.95%14.9M
88.45%4.24M
267.50%4.25M
708.47%3.91M
1,382.74%2.49M
816.48%4.06M
1,745.08%2.25M
848.36%1.16M
398.97%484K
Non-operating interest income
75.67%4.38M
266.95%14.9M
88.45%4.24M
267.50%4.25M
708.47%3.91M
1,382.74%2.49M
816.48%4.06M
1,745.08%2.25M
848.36%1.16M
398.97%484K
Other net income (expense)
90.26%-19K
-151.25%-201K
-38.03%44K
63.95%-31K
75.64%-19K
-1,600.00%-195K
46.31%-80K
646.15%71K
-86K
-36.84%-78K
Other non- operating income (expenses)
90.26%-19K
-151.25%-201K
-38.03%44K
63.95%-31K
75.64%-19K
-1,600.00%-195K
46.31%-80K
646.15%71K
---86K
-36.84%-78K
Income before tax
724.66%210.67M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
-1.47%-127.39M
7.35%-34.19M
7.61%-31.23M
-33.06%-41.04M
Income tax
3.33M
0
Net income
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
-1.47%-127.39M
7.35%-34.19M
7.61%-31.23M
-33.06%-41.04M
Net income continuous Operations
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
-1.47%-127.39M
7.35%-34.19M
7.61%-31.23M
-33.06%-41.04M
Minority interest income
Net income attributable to the parent company
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
-1.47%-127.39M
7.35%-34.19M
7.61%-31.23M
-33.06%-41.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
714.80%207.34M
38.02%-78.96M
179.94%27.34M
-9.20%-34.11M
6.28%-38.46M
-61.13%-33.73M
-1.47%-127.39M
7.35%-34.19M
7.61%-31.23M
-33.06%-41.04M
Basic earnings per share
608.96%3.41
46.54%-1.39
165.22%0.45
9.38%-0.58
19.05%-0.68
-55.81%-0.67
4.06%-2.6
10.39%-0.69
8.57%-0.64
-21.74%-0.84
Diluted earnings per share
586.57%3.26
46.54%-1.39
163.77%0.44
9.38%-0.58
19.05%-0.68
-55.81%-0.67
4.06%-2.6
10.39%-0.69
8.57%-0.64
-21.74%-0.84
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 254.95M125.73%60M60M000-2.84%26.58M00-62.08%859K
Operating revenue --254.95M125.73%60M--60M--0--0--0-2.84%26.58M--0--0-62.08%859K
Cost of revenue
Gross profit
Operating expense 35.04%48.64M-2.72%153.65M1.19%36.95M18.65%38.33M0.12%42.35M-23.09%36.02M3.10%157.95M-19.98%36.52M-26.94%32.3M27.62%42.3M
Selling and administrative expenses 73.27%14.91M5.52%33.49M21.41%8.05M11.03%7.66M19.26%9.17M-18.16%8.61M16.70%31.74M-8.65%6.63M-4.89%6.9M14.53%7.69M
-General and administrative expense 73.27%14.91M5.52%33.49M21.41%8.05M11.03%7.66M19.26%9.17M-18.16%8.61M16.70%31.74M-8.65%6.63M-4.89%6.9M14.53%7.69M
Research and development costs 23.04%33.73M-4.80%120.16M-3.30%28.9M20.71%30.66M-4.13%33.18M-24.51%27.42M0.17%126.22M-22.12%29.88M-31.26%25.4M30.94%34.61M
Operating profit 672.75%206.31M28.71%-93.65M163.12%23.05M-18.65%-38.33M-2.20%-42.35M-70.63%-36.02M-4.39%-131.37M1.35%-36.52M4.78%-32.3M-34.20%-41.44M
Net non-operating interest income expense 75.67%4.38M266.95%14.9M88.45%4.24M267.50%4.25M708.47%3.91M1,382.74%2.49M816.48%4.06M1,745.08%2.25M848.36%1.16M398.97%484K
Non-operating interest income 75.67%4.38M266.95%14.9M88.45%4.24M267.50%4.25M708.47%3.91M1,382.74%2.49M816.48%4.06M1,745.08%2.25M848.36%1.16M398.97%484K
Other net income (expense) 90.26%-19K-151.25%-201K-38.03%44K63.95%-31K75.64%-19K-1,600.00%-195K46.31%-80K646.15%71K-86K-36.84%-78K
Other non- operating income (expenses) 90.26%-19K-151.25%-201K-38.03%44K63.95%-31K75.64%-19K-1,600.00%-195K46.31%-80K646.15%71K---86K-36.84%-78K
Income before tax 724.66%210.67M38.02%-78.96M179.94%27.34M-9.20%-34.11M6.28%-38.46M-61.13%-33.73M-1.47%-127.39M7.35%-34.19M7.61%-31.23M-33.06%-41.04M
Income tax 3.33M0
Net income 714.80%207.34M38.02%-78.96M179.94%27.34M-9.20%-34.11M6.28%-38.46M-61.13%-33.73M-1.47%-127.39M7.35%-34.19M7.61%-31.23M-33.06%-41.04M
Net income continuous Operations 714.80%207.34M38.02%-78.96M179.94%27.34M-9.20%-34.11M6.28%-38.46M-61.13%-33.73M-1.47%-127.39M7.35%-34.19M7.61%-31.23M-33.06%-41.04M
Minority interest income
Net income attributable to the parent company 714.80%207.34M38.02%-78.96M179.94%27.34M-9.20%-34.11M6.28%-38.46M-61.13%-33.73M-1.47%-127.39M7.35%-34.19M7.61%-31.23M-33.06%-41.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 714.80%207.34M38.02%-78.96M179.94%27.34M-9.20%-34.11M6.28%-38.46M-61.13%-33.73M-1.47%-127.39M7.35%-34.19M7.61%-31.23M-33.06%-41.04M
Basic earnings per share 608.96%3.4146.54%-1.39165.22%0.459.38%-0.5819.05%-0.68-55.81%-0.674.06%-2.610.39%-0.698.57%-0.64-21.74%-0.84
Diluted earnings per share 586.57%3.2646.54%-1.39163.77%0.449.38%-0.5819.05%-0.68-55.81%-0.674.06%-2.610.39%-0.698.57%-0.64-21.74%-0.84
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg